These observations support our notion that ZEB1 induces VEGF production by breast cancer cells through activation of the PI3K and p38 pathways, which effect is mediated via increased activity and recruitment of SP1 to the VEGF promoter. This evidence concerns the gene VEGFA and breast carcinoma.